Femrx(fmrx) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Femrx(fmrx)

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: trevor john wilkinson who wrote ()	1/27/1997 4:40:00 PM
From: James Silverman	of 35

Yes Trevor, I do know a little bit about the company. I have been looking into them of late but still have a lot to uncover as to their potential. They are marketing a product for Abnormal Uteran Bleeding (AUB) it is noninvasive and is marketed to be a replacement for hysterectomies. Anectodal remarks I have heard have been quite positive and the product definitely fills a need. $27M market value, $20M cash on hand. Sales slow, but they just began marketing in October. I need to find out more as to what they have in terms of a potential recurring revenue stream and when they expect sales to ramp up to meaningful levels. In the meantime I purchased some shares as their appears to be little downside left, given the cash to market value.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext